Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Task force report on non-criteria manifestations: Thrombocytopenia
Gabriel A. Hernández-Molina
, Xavier López-Karpovitch
, Emilio B. González
, Antonio R. Cabral
Internal Medicine
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Task force report on non-criteria manifestations: Thrombocytopenia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antiphospholipid Syndrome
100%
Thrombocytopenia
100%
Task Force Report
100%
Non-criteria Manifestations
100%
Antiphospholipid Antibodies
66%
Immune Thrombocytopenic Purpura
66%
Thrombosis
33%
Clinical Manifestations
16%
Expert Opinion
16%
Current Therapeutics
16%
Therapeutic Decision-making
16%
Lupus Anticoagulant
16%
Clinical Differences
16%
Classification Criteria
16%
Clinical Similarity
16%
International Consensus
16%
Anticoagulant Activity
16%
Antibody-associated
16%
Consensus Document
16%
Opinion Consensus
16%
Pregnancy Morbidity
16%
Antiphospholipid Antibody Profile
16%
Thrombotic Manifestations
16%
Platelet Destruction
16%
Syndrome Classification
16%
Medicine and Dentistry
Antiphospholipid Syndrome
100%
Thrombocytopenia
100%
Antiphospholipid Antibody
83%
Idiopathic Thrombocytopenic Purpura
66%
Thrombosis
33%
Platelet
16%
Anticoagulation
16%
Clinical Syndrome
16%
Lupus Anticoagulant
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antiphospholipid Syndrome
100%
Thrombocytopenia
100%
Antiphospholipid Antibody
83%
Idiopathic Thrombocytopenic Purpura
66%
Thrombosis
33%
Lupus Anticoagulant
16%
Anticoagulant Activity
16%
Immunology and Microbiology
Antiphospholipid Syndrome
100%
Antiphospholipid Antibody
83%
Idiopathic Thrombocytopenic Purpura
66%
Platelet
16%
Anticoagulation
16%
Lupus Anticoagulant
16%